RVL Pharmaceuticals plc Tops Q2 EPS by 10c

  • Investing.com
RVL Pharmaceuticals plc Tops Q2 EPS by 10c

RVL Pharmaceuticals plc (RVLP) reported Q2 EPS of ($0.14), $0.10 better than the analyst estimate of ($0.24). Revenue for the quarter came in at $8.4 million versus the consensus estimate of $8.72 million.

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

100